Reciprocal Copy Number Variations at 22q11.2 Produce Distinct and Convergent Neurobehavioral Impairments Relevant for Schizophrenia and Autism Spectrum Disorder.


Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 21 07 2019
revised: 12 12 2019
accepted: 30 12 2019
pubmed: 8 3 2020
medline: 20 2 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

22q11.2 deletions and duplications are copy number variations (CNVs) that predispose to developmental neuropsychiatric disorders. Both CNVs are associated with autism spectrum disorder (ASD), while the deletion confers disproportionate risk for schizophrenia. Neurobehavioral profiles associated with these reciprocal CNVs in conjunction with brain imaging measures have not been reported. We profiled the impact of 22q11.2 CNVs on neurobehavioral measures relevant to ASD and psychosis in 106 22q11.2 deletion carriers, 38 22q11.2 duplication carriers, and 82 demographically matched healthy control subjects. To determine whether brain-behavior relationships were altered in CNV carriers, we further tested for interactions between group and regional brain structure on neurobehavioral domains. Cognitive deficits were observed in both CNV groups, with the lowest IQs in deletion carriers. ASD and dimensionally measured ASD traits were elevated in both CNV groups; however, duplication carriers exhibited increased stereotypies compared to deletion carriers. Moreover, discriminant analysis using ASD subdomains distinguished between CNV cases with 76% accuracy. Both psychotic disorder diagnosis and dimensionally measured positive and negative symptoms were elevated in deletion carriers. Finally, healthy control subjects showed an inverse relationship between processing speed and cortical thickness in heteromodal association areas, which was absent in both CNV groups. 22q11.2 CNVs differentially modulate intellectual functioning and psychosis-related symptomatology but converge on broad ASD-related symptomatology. However, subtle differences in ASD profiles distinguish CNV groups. Processing speed impairments, coupled with the lack of normative relationship between processing speed and cortical thickness in CNV carriers, implicate aberrant development of the cortical mantle in the pathology underlying impaired processing speed ability.

Sections du résumé

BACKGROUND
22q11.2 deletions and duplications are copy number variations (CNVs) that predispose to developmental neuropsychiatric disorders. Both CNVs are associated with autism spectrum disorder (ASD), while the deletion confers disproportionate risk for schizophrenia. Neurobehavioral profiles associated with these reciprocal CNVs in conjunction with brain imaging measures have not been reported.
METHODS
We profiled the impact of 22q11.2 CNVs on neurobehavioral measures relevant to ASD and psychosis in 106 22q11.2 deletion carriers, 38 22q11.2 duplication carriers, and 82 demographically matched healthy control subjects. To determine whether brain-behavior relationships were altered in CNV carriers, we further tested for interactions between group and regional brain structure on neurobehavioral domains.
RESULTS
Cognitive deficits were observed in both CNV groups, with the lowest IQs in deletion carriers. ASD and dimensionally measured ASD traits were elevated in both CNV groups; however, duplication carriers exhibited increased stereotypies compared to deletion carriers. Moreover, discriminant analysis using ASD subdomains distinguished between CNV cases with 76% accuracy. Both psychotic disorder diagnosis and dimensionally measured positive and negative symptoms were elevated in deletion carriers. Finally, healthy control subjects showed an inverse relationship between processing speed and cortical thickness in heteromodal association areas, which was absent in both CNV groups.
CONCLUSIONS
22q11.2 CNVs differentially modulate intellectual functioning and psychosis-related symptomatology but converge on broad ASD-related symptomatology. However, subtle differences in ASD profiles distinguish CNV groups. Processing speed impairments, coupled with the lack of normative relationship between processing speed and cortical thickness in CNV carriers, implicate aberrant development of the cortical mantle in the pathology underlying impaired processing speed ability.

Identifiants

pubmed: 32143830
pii: S0006-3223(20)30006-8
doi: 10.1016/j.biopsych.2019.12.028
pmc: PMC7354903
mid: NIHMS1572021
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

260-272

Subventions

Organisme : NIMH NIH HHS
ID : F31 MH117872
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH073526
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH101719
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH116473
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085953
Pays : United States

Informations de copyright

Copyright © 2020 Society of Biological Psychiatry. All rights reserved.

Références

Br J Psychiatry. 2008 Nov;193(5):364-72
pubmed: 18978313
Nat Genet. 2017 Jan;49(1):27-35
pubmed: 27869829
Arch Gen Psychiatry. 2007 May;64(5):532-42
pubmed: 17485605
Clin Genet. 2008 Feb;73(2):160-4
pubmed: 18076674
Hum Mol Genet. 2011 Dec 15;20(24):4775-85
pubmed: 21908517
Schizophr Res. 2014 Jan;152(1):117-23
pubmed: 24321711
Am J Psychiatry. 2010 Feb;167(2):160-9
pubmed: 20048021
Br J Psychiatry. 2014 Feb;204(2):108-14
pubmed: 24311552
Schizophr Res. 2012 Mar;135(1-3):72-8
pubmed: 22226902
Lancet Psychiatry. 2019 Jun;6(6):493-505
pubmed: 31056457
Mol Autism. 2014 Feb 11;5(1):11
pubmed: 24517317
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):53-65
pubmed: 28367513
Biol Psychiatry. 2014 Mar 1;75(5):378-85
pubmed: 23992924
World Psychiatry. 2014 Feb;13(1):28-35
pubmed: 24497240
Mol Psychiatry. 2018 Apr;23(4):932-942
pubmed: 28461699
Neuroimage Clin. 2013 Oct 14;3:405-15
pubmed: 24273724
Neuron. 2012 Mar 22;73(6):1063-7
pubmed: 22445335
Acta Psychol (Amst). 1994 Aug;86(2-3):199-225
pubmed: 7976467
Biol Psychiatry. 2016 Aug 15;80(4):331-337
pubmed: 26795442
Mol Psychiatry. 2018 Apr;23(4):985-992
pubmed: 28827761
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1060-1068
pubmed: 19797984
Cell. 2012 Mar 16;148(6):1223-41
pubmed: 22424231
Mol Psychiatry. 2016 Apr;21(4):585
pubmed: 26283641
Hum Mol Genet. 2009 Oct 15;18(20):3914-25
pubmed: 19617637
Mol Genet Genomic Med. 2019 Feb;7(2):e00507
pubmed: 30614210
Nature. 2014 Jan 16;505(7483):361-6
pubmed: 24352232
J Neurosci. 2011 Aug 10;31(32):11597-616
pubmed: 21832190
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13504-13509
pubmed: 27834215
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):242-9
pubmed: 17034022
J Neurodev Disord. 2015;7(1):18
pubmed: 26137170
J Neurosci. 2013 May 29;33(22):9408-19
pubmed: 23719809
Psychol Med. 2010 Apr;40(4):569-79
pubmed: 19671209
Mol Psychiatry. 2017 Dec;22(12):1664-1672
pubmed: 28761081
JAMA Psychiatry. 2017 Mar 1;74(3):282-290
pubmed: 28114601
JAMA. 2015 May 26;313(20):2044-54
pubmed: 26010633
Transl Psychiatry. 2019 Jan 16;9(1):8
pubmed: 30664628
J Neurosci Methods. 2010 Mar 30;187(2):254-62
pubmed: 19945485
Mol Psychiatry. 2018 May;23(5):1261-1269
pubmed: 29038599
Genet Med. 2008 Apr;10(4):267-77
pubmed: 18414210
Schizophr Res. 2000 Apr 7;42(2):145-55
pubmed: 10742652
Mol Psychiatry. 2013 Nov;18(11):1153-65
pubmed: 23917946
Neuroimage. 2004 Mar;21(3):1174-81
pubmed: 15006684
J Neurosci. 2017 Aug 23;37(34):8227-8238
pubmed: 28743724
Am J Psychiatry. 2003 May;160(5):815-24
pubmed: 12727681
Acta Psychol (Amst). 2004 Oct;117(2):155-83
pubmed: 15464012
Am J Hum Genet. 2003 Nov;73(5):1027-40
pubmed: 14526392
Br J Psychiatry. 2018 May;212(5):287-294
pubmed: 29693535
Am J Psychiatry. 2014 Jun;171(6):627-39
pubmed: 24577245
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Mol Psychiatry. 2018 Jun 13;:
pubmed: 29895892
Mol Psychiatry. 2014 Jan;19(1):37-40
pubmed: 24217254
Br J Psychiatry. 2014 Jan;204(1):46-54
pubmed: 24115343
JAMA Psychiatry. 2016 Jan;73(1):20-30
pubmed: 26629640
Br J Psychiatry. 2019 May;214(5):297-304
pubmed: 30767844
Behav Brain Res. 2010 Jun 26;210(1):116-22
pubmed: 20178817
Schizophr Res. 2014 Mar;153(1-3):231-6
pubmed: 24534796
Int J Neuropsychopharmacol. 2019 Aug 1;22(8):488-500
pubmed: 31135887
Biol Psychol. 2000 Oct;54(1-3):1-34
pubmed: 11035218
Biol Psychiatry. 2016 Jul 15;80(2):129-139
pubmed: 26742926
J Autism Dev Disord. 2007 May;37(5):855-66
pubmed: 17048092
Biol Psychiatry. 2015 May 1;77(9):785-93
pubmed: 25064419
J Autism Dev Disord. 2018 Aug;48(8):2653-2662
pubmed: 29500756
Eur J Med Genet. 2008 Nov-Dec;51(6):501-10
pubmed: 18707033
Mol Psychiatry. 2019 Jul 29;:
pubmed: 31358905
Schizophr Bull. 2007 Sep;33(5):1247-56
pubmed: 17255120
JAMA Psychiatry. 2017 Sep 1;74(9):958-966
pubmed: 28768312
Schizophr Res. 2006 Oct;87(1-3):270-8
pubmed: 16753283
Schizophr Res. 2017 Oct;188:59-62
pubmed: 28119035
J Neurosci. 2013 Sep 11;33(37):14825-39
pubmed: 24027283
Eur J Med Genet. 2009 Mar-Jun;52(2-3):88-93
pubmed: 19254783
JAMA Psychiatry. 2016 Sep 1;73(9):963-969
pubmed: 27602560
J Autism Dev Disord. 2012 May;42(5):655-64
pubmed: 21638108
Cereb Cortex. 2010 Mar;20(3):534-48
pubmed: 19520764
Neuroreport. 2007 Jan 8;18(1):23-7
pubmed: 17259855
J Neurodev Disord. 2009 Jun;1(2):114-32
pubmed: 21547711
Nat Rev Neurosci. 2013 Nov;14(11):810-4
pubmed: 24135697
Neuron. 2015 May 6;86(3):680-95
pubmed: 25913858
Disabil Rehabil. 2006 Dec 30;28(24):1529-42
pubmed: 17178616
Prenat Diagn. 2015 Aug;35(8):801-9
pubmed: 25962607
PLoS One. 2010 May 28;5(5):e10887
pubmed: 20526357
J Neurosci. 2017 Jun 28;37(26):6183-6199
pubmed: 28536274
JAMA Psychiatry. 2015 Apr;72(4):377-85
pubmed: 25715178
Hum Mol Genet. 2008 Dec 15;17(24):4045-53
pubmed: 18806272
Trends Cogn Sci. 2005 Feb;9(2):60-8
pubmed: 15668098
Prog Neurobiol. 2015 Jul;130:1-28
pubmed: 25866365
Am J Psychiatry. 2003 Nov;160(11):2060-2
pubmed: 14594759
Lancet Psychiatry. 2018 Jul;5(7):573-580
pubmed: 29886042
Br J Psychiatry Suppl. 2007 Dec;51:s107-10
pubmed: 18055925
Mol Autism. 2016 May 06;7:27
pubmed: 27158440
Schizophr Res. 2013 Jan;143(1):55-9
pubmed: 23153825

Auteurs

Amy Lin (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Ariana Vajdi (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Leila Kushan-Wells (L)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Gerhard Helleman (G)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Laura Pacheco Hansen (LP)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Rachel K Jonas (RK)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California.

Maria Jalbrzikowski (M)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania.

Lyle Kingsbury (L)

Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, California; Department of Neurobiology, University of California, Los Angeles, Los Angeles, California.

Armin Raznahan (A)

Developmental Neurogenomics Unit, Human Genetics Branch, National Institute of Mental Health, Bethesda, Maryland.

Carrie E Bearden (CE)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, California; Department of Psychology, University of California, Los Angeles, Los Angeles, California. Electronic address: CBearden@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH